Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

CUPRIMINE

PENICILLAMINE

Standard Dose
250MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CUPRIMINE is listed in Drugs@FDA under application 019853 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient PENICILLAMINE Form and strength CAPSULE;ORAL - 250MG Sponsor VALEANT PHARMS INTL Submission history Latest submission status date: 2004-10-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview CUPRIMINE is listed in Drugs@FDA under application 019853 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PENICILLAMINE Form and strength CAPSULE;ORAL - 250MG Sponsor VALEANT PHARMS INTL Submission history Latest submission status date: 2004-10-26 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
CUPRIMINE (PENICILLAMINE) | Drug Monograph | MedicHelpline